Almaral

Moncyte Health is a personalized medicine company focused on transforming the treatment and prevention of cardiovascular disease, particularly high cholesterol. The company has developed a patented technology that includes a cellular mechanism analysis test designed to identify patients who are unlikely to respond to traditional statin treatments. By providing insights into individual patient responses, Moncyte enables healthcare providers to make informed, data-driven treatment decisions, thereby optimizing patient outcomes in managing high cholesterol.

Fepod is a company focused on enhancing patient care through innovative healthcare technology. It has developed a portable electrochemical analysis tool designed to accurately measure the blood concentration of medications, such as paracetamol and opioids. This tool features mass-producible, disposable sampling sensors that are compatible with an affordable analytical device that connects to a standard smartphone. By providing healthcare professionals with precise measurements, Fepod aims to facilitate improved and personalized treatment for patients, ultimately contributing to more confident decision-making in clinical settings.

Marginum is a university-based medical technology startup focused on developing fluorescence-based tissue detection systems aimed at improving cancer treatment outcomes. The company creates innovative, data-driven solutions that enhance the monitoring of tissues during cancer surgeries and treatments. By leveraging cutting-edge research, Marginum's products are designed to optimize surgical performance while also increasing cost-effectiveness in healthcare. The multidisciplinary team at Marginum collaborates closely with academic, clinical, and industrial experts to ensure that its technological solutions are seamlessly integrated into clinical practice.

Seppo is a Finnish start-up focused on game-based learning, offering an interactive platform that leverages mobile technology and gamification for corporate training, strategy communication, and change management. The platform enables users to create engaging learning experiences without coding, utilizing various environments such as 360-degree images and 3D worlds. Seppo's solutions encourage deep analysis, collaboration, and self-reflection among participants, moving beyond traditional quizzes. The platform is powered by artificial intelligence, allowing users to transform training materials into interactive games quickly. Additionally, Seppo provides a comprehensive Content Library filled with pre-made games. The company operates on an automated recurring Software as a Service (SaaS) model and has achieved an annual recurring revenue of 1 million euros.

Fepod is a company focused on enhancing patient care through innovative healthcare technology. It has developed a portable electrochemical analysis tool designed to accurately measure the blood concentration of medications, such as paracetamol and opioids. This tool features mass-producible, disposable sampling sensors that are compatible with an affordable analytical device that connects to a standard smartphone. By providing healthcare professionals with precise measurements, Fepod aims to facilitate improved and personalized treatment for patients, ultimately contributing to more confident decision-making in clinical settings.